Michael Sassano
Amministratore Delegato presso Somaí Pharmaceuticals Ltd.
Posizioni attive di Michael Sassano
Società | Posizione | Inizio | Fine |
---|---|---|---|
Somaí Pharmaceuticals Ltd.
Somaí Pharmaceuticals Ltd. BiotechnologyHealth Technology SOMAí Pharmaceuticals Ltd. is a European pharmaceutical and Irish biotech company that was founded in 2019 by Michael Sassano and George Bellow. The company is based in Dublin, Ireland. SOMAí Pharmaceuticals is a large-scale manufacturer of cannabis products that invests in the extraction, research, development, formulation, and distribution of EU GMP-pharmaceutical market-authorized cannabinoid products. The company is committed to revolutionizing healthcare through cannabis-based treatments and emphasizes scientific pharmacology applications with EU-GMP standards to deliver treatments to the endocannabinoid system. SOMAí Pharmaceuticals is the largest and most advanced cannabinoid manufacturing facility in markets, producing medicines products and registered APIs. Michael Sassano has been the CEO since 2019. | Amministratore Delegato | 19/02/2019 | - |
Presidente | 19/02/2019 | - | |
Fondatore | 19/02/2019 | - |
Storia della carriera di Michael Sassano
Statistiche
Distribuzione geografica
Irlanda | 2 |
Posizioni
Chief Executive Officer | 1 |
Chairman | 1 |
Founder | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Somaí Pharmaceuticals Ltd.
Somaí Pharmaceuticals Ltd. BiotechnologyHealth Technology SOMAí Pharmaceuticals Ltd. is a European pharmaceutical and Irish biotech company that was founded in 2019 by Michael Sassano and George Bellow. The company is based in Dublin, Ireland. SOMAí Pharmaceuticals is a large-scale manufacturer of cannabis products that invests in the extraction, research, development, formulation, and distribution of EU GMP-pharmaceutical market-authorized cannabinoid products. The company is committed to revolutionizing healthcare through cannabis-based treatments and emphasizes scientific pharmacology applications with EU-GMP standards to deliver treatments to the endocannabinoid system. SOMAí Pharmaceuticals is the largest and most advanced cannabinoid manufacturing facility in markets, producing medicines products and registered APIs. Michael Sassano has been the CEO since 2019. | Health Technology |
- Borsa valori
- Insiders
- Michael Sassano
- Esperienza